Your browser doesn't support javascript.
loading
Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma.
Karvonen, Hanna; Chiron, David; Niininen, Wilhelmiina; Ek, Sara; Jerkeman, Mats; Moradi, Elaheh; Nykter, Matti; Heckman, Caroline A; Kallioniemi, Olli; Murumägi, Astrid; Ungureanu, Daniela.
Afiliación
  • Karvonen H; BioMediTech Institute and.
  • Chiron D; Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
  • Niininen W; Centre de Recherche en Cancérologie et Immunologie Nantes Angers, INSERM, Centre National de la Recherche Scientifique, Université de Nantes, Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Ek S; BioMediTech Institute and.
  • Jerkeman M; Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
  • Moradi E; Department of Immunotechnology, Faculty of Engineering, and.
  • Nykter M; Department of Oncology and Pathology, Institute of Clinical Sciences, Lund University, Lund, Sweden.
  • Heckman CA; BioMediTech Institute and.
  • Kallioniemi O; Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
  • Murumägi A; BioMediTech Institute and.
  • Ungureanu D; Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Blood Adv ; 1(24): 2257-2268, 2017 Nov 14.
Article en En | MEDLINE | ID: mdl-29296874

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Blood Adv Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Blood Adv Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos